东欧HPV筛查最优方案:以斯洛文尼亚为例
该研究用MISCAN-Cervix微模拟模型评估968种HPV筛查方案的成本效果,以斯洛文尼亚为例。在可接受方案中,最优为25和28岁两次细胞学后30至65岁每5年HPV筛查;若不受限,仅30至65岁每5年HPV筛查成本效果提高5%。分型可改善成本效果,结果对东欧其他情况稳健。
要点
- 斯洛文尼亚可接受的最优方案:25和28岁细胞学,30至65岁每5年HPV筛查。
- 不受社会可接受性限制时,仅30至65岁每5年HPV筛查成本效果提高5%。
- 分型加入分流算法一致改善成本效果,结果对东欧其他情况稳健。
核心结论
- 尽管东欧与西欧宫颈癌流行病学存在差异,HPV筛查最优方案非常相似。
- 社会可接受的方案成本效果几乎不劣于可接受性较低的方案,可作为避免机会性筛查的可行替代。
研究设计与样本
- 使用MISCAN-Cervix微模拟模型评估968种HPV筛查方案。
- 方案在筛查年龄、分流检测(细胞学、重复HPV和/或分型)及35岁以下女性策略上有所不同。
主要发现
- 在斯洛文尼亚女性可接受的策略子集中,最优方案为25和28岁两次细胞学后30至65岁每5年HPV筛查。
- 考虑所有方案时,最优策略为仅30至65岁每5年HPV筛查,成本效果提高5%。
- 分型加入分流算法一致改善成本效果,敏感性分析显示结果对东欧其他情况稳健。
临床怎么用
- 东欧国家引入HPV初筛时可参考斯洛文尼亚经验,优先选择社会可接受的方案。
- 分型可用于分流算法以改善成本效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Eastern European countries are contemplating to introduce the high-risk Human Papillomavirus (HPV)-test as the primary screening test for their cervical cancer screening programme, but its optimal protocol is yet unknown. The aim of this study was to compare the costs, effects and cost-effectiveness of different primary HPV-screening protocols in Eastern Europe, using Slovenia as an example and with respect of local preferences for screening. METHODS: We evaluated 968 HPV-screening protocols, which varied by screening ages, triage tests (i.e. cytology, repeat HPV and/or genotyping) and strategy for women under 35 years old, using the microsimulation model MISCAN-Cervix. RESULTS: Within the subset of strategies that would be acceptable for Slovenian women, the optimal HPV-screening protocol is to start with two cytology tests at age 25 and 28 and switch to 5-yearly HPV screening from age 30 to 65. When also other protocols were considered, the optimal screening strategy would be 5-yearly HPV screening from age 30 to 65 only, improving the cost-effectiveness with 5%. Adding genotyping in the triage algorithm consistently improved cost-effectiveness. Sensitivity analyses showed the robustness of the results for other situations in Eastern Europe. CONCLUSIONS: Despite differences in cervical cancer epidemiology between Eastern and Western European regions where HPV screening was evaluated, the optimal screening protocol was found to be very similar. Furthermore, strategies that were considered socially acceptable to the population were found to be almost as cost-effective as less acceptable strategies and can therefore be considered a viable alternative to prevent opportunistic screening.
引用
- Jansen EEL, Ivanuš U, Jerman T, et al. The optimal HPV-screening protocol in Eastern-Europe: The example of Slovenia. Gynecol Oncol. 2020. PMID: 33199028. doi:10.1016/j.ygyno.2020.10.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。